Gönül Veliçelebi
Directeur Général chez Camino Pharma LLC
Postes actifs de Gönül Veliçelebi
Sociétés | Poste | Début | Fin |
---|---|---|---|
Orphagen Pharmaceuticals
Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 08/01/2013 | - |
Camino Pharma LLC
Camino Pharma LLC BiotechnologyHealth Technology Camino Pharma LLC is a start-up company based in the United States that focuses on discovering and developing first-in-class therapies for cancer and CNS disorders. The American company targets signaling proteins based on emerging biological concepts and discovers novel mechanisms for modulating these targets with small molecule drugs. Camino Pharma's leadership team has proven expertise in relevant target biology and extensive experience in drug discovery and development. The private company's goal is to discover and develop novel, first-in-class treatments for the most aggressive forms of cancer and poorly addressed psychiatric disorders, including substance use and major depression. Camino Pharma's innovative technology platform allows for exploiting inadequately served targets that require a highly adaptive and specialized approach to drug discovery. | Directeur Général | 01/09/2014 | - |
Fondateur | 01/09/2014 | - |
Historique de carrière de Gönül Veliçelebi
Anciens postes connus de Gönül Veliçelebi
Sociétés | Poste | Début | Fin |
---|---|---|---|
TorreyPines Therapeutics, Inc. /Old/
TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, formerly Neurogenetics, Inc., was founded in 2000. The company discovers & develops small molecule drugs to treat diseases and disorders of the central nervous system. The company is located in La Jolla, CA | Directeur Technique/Scientifique/R&D | 01/01/2000 | 06/10/2006 |
CALCIMEDICA, INC. | Fondateur | 01/01/2017 | - |
Sibia Neurosciences, Inc. | Corporate Officer/Principal | - | - |
MitoKor, Inc.
MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | Directeur Technique/Scientifique/R&D | - | - |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Directeur Technique/Scientifique/R&D | - | - |
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Directeur/Membre du Conseil | 01/12/2006 | - |
Directeur Général | 01/12/2006 | - | |
Fondateur | 11/08/2009 | - | |
President | 01/12/2006 | - |
Formation de Gönül Veliçelebi
Yale University | Doctorate Degree |
Randolph College, Inc. | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 11 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Founder | 3 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 9 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
CALCIMEDICA, INC. | Health Technology |
Entreprise privées | 7 |
---|---|
TorreyPines Therapeutics, Inc. /Old/
TorreyPines Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, formerly Neurogenetics, Inc., was founded in 2000. The company discovers & develops small molecule drugs to treat diseases and disorders of the central nervous system. The company is located in La Jolla, CA | Health Technology |
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
TorreyPines Therapeutics, Inc.
TorreyPines Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TorreyPines Therapeutics, Inc. manufactures and distributes biopharmaceutical products. The company develops small molecule drugs to treat diseases and disorders of the central nervous system, chronic pain, neuropathic pain, cognitive disorders and alzheimer's disease. It was formerly known as Axonyx, Inc. The company is headquartered in La Jolla, CA. | Health Technology |
MitoKor, Inc.
MitoKor, Inc. BiotechnologyHealth Technology MitoKor, Inc. provided discovery and diagnostic development of mitochondrial medicine. It was a biotechnology company focused on the research and development of drugs for the treatment of major diseases and conditions associated with mitochondrial dysfunction. The company was headquartered in San Diego, CA | Health Technology |
Sibia Neurosciences, Inc. | Health Technology |
Orphagen Pharmaceuticals
Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA. | Health Technology |
Camino Pharma LLC
Camino Pharma LLC BiotechnologyHealth Technology Camino Pharma LLC is a start-up company based in the United States that focuses on discovering and developing first-in-class therapies for cancer and CNS disorders. The American company targets signaling proteins based on emerging biological concepts and discovers novel mechanisms for modulating these targets with small molecule drugs. Camino Pharma's leadership team has proven expertise in relevant target biology and extensive experience in drug discovery and development. The private company's goal is to discover and develop novel, first-in-class treatments for the most aggressive forms of cancer and poorly addressed psychiatric disorders, including substance use and major depression. Camino Pharma's innovative technology platform allows for exploiting inadequately served targets that require a highly adaptive and specialized approach to drug discovery. | Health Technology |
- Bourse
- Insiders
- Gönül Veliçelebi
- Expérience